Therapeutic EUS is a growing and exciting field that is advancing endoscopic treatments for patients with complex pancreaticobiliary diseases. This web page includes physician videos and case studies, and a step by step reference guide for the AXIOS™ Stent and Delivery System.*
Presentations & Video Case Studies
Dr. Sethi shares indications for PFC drainage, compares the AXIOS 20mm Stent to other sizes of LAMS, and presents her initial cases and experiences placing the 20mm AXIOS Stent.
Dr. Adler shares his experience, best practices, and case studies using the 20mm AXIOS Stent.
Dr. Khashab treats a symptomatic pseudocyst by placing an AXIOS™ Stent.
Dr. Sanchez-Yague places an AXIOS™ Stent to treat WON.
Dr. Varadarajulu uses the AXIOS System to drain a symptomatic pancreatic pseudocyst.
Focus on LAMS Technology
Dr. Binmoeller, founder of Xlumena and inventor of the AXIOS System, discusses the features and intended benefits of the AXIOS Stent and Delivery System.
Dr. Binmoeller talks about the future of interventional endoscopy and his passion for being inventive and innovative that led to the development of the AXIOS technology.
The AXIOS Stent and Delivery System and the AXIOS Electrocautery Enhanced Stent and Delivery System Indications for Use:
• U.S.: The AXIOS Stent and Delivery System and the AXIOS Electrocautery Enhanced Stent and Delivery System is indicated for use to facilitate transgastric or transduodenal endoscopic drainage of symptomatic pancreatic pseudocysts =/>6cm in size and walled-off necrosis =/>6cm in size with =/>70% fluid content that are adherent to the gastric or bowel wall. Once placed, the AXIOS Stent functions as an access port allowing passage of standard and therapeutic endoscopes to facilitate debridement, irrigation and cystoscopy. The stent is intended for implantation up to 60 days and should be removed upon confirmation of pseudocyst or walled-off necrosis resolution.
• Europe: The HOT AXIOS Stent and Electrocautery Enhanced Delivery System & the AXIOS Stent and Delivery System are indicated for use to facilitate transgastric or transduodenal endoscopic drainage of a pancreatic pseudocyst or a walled-off necrosis with =/>70% fluid content or the biliary tract.